Feds take case for possible saline price fixing to grand jury, Baxter discloses

Fierce Pharma -------- The chance that some drugmakers will be charged for fixing the price of their saline solution has escalated as a federal probe has moved from the investigation phase to a federal courtroom where federal prosecutors are presenting evidence to a grand jury. Notice of the new phase came in an SEC filing from Baxter International on Friday, in which it said that one of its employees received a grand jury subpoena from a federal court in Pennsylvania for an investigation by the Justice Department’s antitrust division. The subpoena ordered the employee to provide documents and testimony about the manufacture, pricing and shortages of saline solution and other injectables. It also wants info about and any communications the company had with competitors about any of that, Baxter reported. The drugmaker, which said it is cooperating, said it earlier got a request from the New York attorney general’s office to provide info about the saline IV business. To learn more click on the picture below to read the article.